EvolveImmune Therapeutics logo

EvolveImmune Therapeutics

Website

Team & Investors

Leadership, board of directors, and investment partners

Executives
0
Board Members
0
Investors
8
Total Funding
$103.2M
Investors
8 investors across all rounds
A
AbbVie
BS
Bristol-Myers Squibb
ES
Elm Street Ventures
PV
Pfizer Ventures
OTHER
SV
Solasta Ventures

+3 more investors

Sign in to view all

Explore More Data
Detailed analysis for EvolveImmune Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

EvolveImmune Therapeutics Leadership & Investors

EvolveImmune Therapeutics is led by a team of experienced leaders. The company has attracted investment from 8 institutional and strategic investors.

Who Has Invested in EvolveImmune Therapeutics?

EvolveImmune Therapeutics has raised $103.2M from 8 investors including venture capital firms, private equity investors, and strategic partners.

Investment Opportunity

Accredited investors can access EvolveImmune Therapeutics shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.